It helped slightly, often preserving lean mass or improving recovery, but it was the combined program that delivered measurable fat loss
Incidences of other toxicities were comparable across the three treatment groups in DURATION-8 (exenatide plus dapagliflozin, exenatide alone, and dapagliflozin alone, respectively), including pancreatitis (1.3%, 0.4%, and 0%), volume depletion (1.3%, 0.4%, and 2.1%), gastrointestinal events (20.8%, 23.9%, and 16.3%), and genital infections (5.2%, 2.2%, and 7.7%) [36]
S., Lightowler, H., Ahlstrom, L., & Gallagher, A
Trends Immunother
Ready to compare your options beyond GLP-1s